| ￥4980 | |
| L00969 | |
|
|
|
|
|
|
|
|
|
| Linearity Range | 39.06-2500 ng/mL (0.78-50 ng/mL diluted) | ||||||||||||||||||||||||||||||
| Sensitivity |
ULOQ: 2500 ng/mL LLOQ: 39.06 ng/mL HQC of 1875 ng/mL MQC: 312.5 ng/mL LQC: 117.18 ng/mL |
||||||||||||||||||||||||||||||
| Precision |
Intra-assay: CV≤10% Inter-assay: CV≤15% |
||||||||||||||||||||||||||||||
| Accuracy | 80%-120% | ||||||||||||||||||||||||||||||
| Standard | 250 µg/mL of Bevacizumab | ||||||||||||||||||||||||||||||
| Specificity | No cross-reactivity at 25,000 ng/mL of Human IgG1 | ||||||||||||||||||||||||||||||
| Assay Temperature | 25 ℃ | ||||||||||||||||||||||||||||||
| Assay Time | 1 h 55 min | ||||||||||||||||||||||||||||||
| Storage | The unopened kit is stable for at least 12 months from the date of manufacture at 2°C to 8°C, and the opened kit is stable for up to 1 month from the date of opening at 2°C to 8°C. | ||||||||||||||||||||||||||||||
| Kit Contents |
|
Figure 1: Bevacizumab ELISA kit standard curve.
A set of Bevacizumab calibration standards from 39.06 ng/mL to 2500 ng/mL was then diluted with Sample Dilution Buffer with a volume ratio of 1:50.
»
»
»
»
»
»
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.
